Palladium-Catalyzed Cycloaddition Reactions of π–Allylpalladium 1,4-Dipoles with 1,3,5-Triazinanes: Access to Hexahydropyrimidines, 1,3-Oxazinanes, and 1,5-Diazocanes-Reference-Cited by-同舟云学术

Palladium-Catalyzed Cycloaddition Reactions of π–Allylpalladium 1,4-Dipoles with 1,3,5-Triazinanes: Access to Hexahydropyrimidines, 1,3-Oxazinanes, and 1,5-Diazocanes

Published:2024-06-07 Issue:12 Volume:89 Page:8363-8375
ISSN:0022-3263
Container-title:The Journal of Organic Chemistry
language:en
Short-container-title:J. Org. Chem.

Author:

Zhang Xin-Hua¹,Wang Zhi-Hui²,Chen Yan³,Bai Mei¹,Wang Zhen-Hua²^ORCID,Zhang Yan-Ping²,You Yong²^ORCID,Zhao Jian-Qiang²^ORCID,Yuan Wei-Cheng²^ORCID

Affiliation:

1. Key Laboratory of Biocatalysis & Chiral Drug Synthesis of Guizhou Province, Generic Drug Research Center of Guizhou Province, Green Pharmaceuticals Engineering Research Center of Guizhou Province, School of Pharmacy, Zunyi Medical University, Zunyi 563000, China

2. Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China

3. China National Engineering Research Center of Chiral Drugs, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, China

Funder

National Natural Science Foundation of China

Sichuan Science and Technology Program

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.joc.4c00128

Reference54 articles.

1. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals

2. Effect-Directed Identification of Oxygen and Sulfur Heterocycles as Major Polycyclic Aromatic Cytochrome P4501A-Inducers in a Contaminated Sediment

3. Review on analytical studies of some pharmaceutical compounds containing heterocyclic rings: brinzolamide, timolol maleate, flumethasone pivalate, and clioquinol

4. An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals

5. Asymmetric organocatalysis: an enabling technology for medicinal chemistry